Griskevica A, Ching P, Russo G, Kreysler J
Department of Epidemiology of Infectious Diseases, National Environmental Health Center, Rìga, Latvia.
J Infect Dis. 2000 Feb;181 Suppl 1:S60-4. doi: 10.1086/315540.
After nearly two decades without a diphtheria case in Latvia, the disease reappeared in 1986. From 1990 to 1996, case counts were highest among adults 40-49 years of age, school-aged children, and adolescents. Nonetheless, the average annualized incidence of disease was highest among infants and preschoolers. In August 1995, mass vaccination efforts began to provide adults 25-60 years of age with at least one dose of vaccine. By the end of the year, a 77% coverage rate was achieved, resulting in a decrease of reported diphtheria cases by 1996. From February to September 1997, special outreach efforts were focused on hard-to-reach populations; as a result, by June 1997, 55% of adults had received three doses of vaccine. While decreases in the incidence of and morbidity from diphtheria have occurred, additional efforts still need to be concentrated on improving vaccination coverage in adults and children <2 years of age and in reducing mortality from diphtheria.
在拉脱维亚近二十年没有白喉病例之后,该病于1986年再度出现。1990年至1996年期间,病例数在40 - 49岁的成年人、学龄儿童和青少年中最多。尽管如此,该病的年均发病率在婴儿和学龄前儿童中最高。1995年8月,大规模疫苗接种工作开始为25至60岁的成年人提供至少一剂疫苗。到年底,接种率达到77%,使得1996年报告的白喉病例有所减少。1997年2月至9月,特别外展工作集中于难以接触到的人群;结果,到1997年6月,55%的成年人接种了三剂疫苗。虽然白喉的发病率和发病情况有所下降,但仍需进一步努力,集中提高成年人和2岁以下儿童的疫苗接种率,并降低白喉死亡率。